Capricor Therapeutics reported 3.05M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 131.3M 9M Mar/2026
Cytokinetics USD 33.34M 3M Mar/2026
Geron USD 7.15M 150K Mar/2026
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
J&J USD 43M 25M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Prothena USD 349.89M 347.27M Mar/2026
PTC Therapeutics USD 2.87B 2.82B Mar/2026
Sarepta Therapeutics USD 20.84M 13.28M Dec/2025